Free Trial

Walker & Dunlop Q4 Earnings Call Highlights

Walker & Dunlop logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Walker & Dunlop saw dramatic deal momentum as transaction volume climbed from $7 billion in Q1 to $18 billion in Q4 (a 161% increase), finishing 2025 as the second-largest GSE loan originator with $17.8 billion in lending and a $15 billion Q1 2026 pipeline while targeting $9 EPS by 2030.
  • A Freddie Mac‑requested review uncovered problem loans, bringing the total under scrutiny to $134 million; the company offered to indemnify Freddie Mac for $134 million, recorded $29 million of Q4 loan loss expense and $66 million of impairments, which drove a GAAP diluted loss per share of $0.41 though management highlighted positive core results (adjusted core EPS and EBITDA materially higher on an add‑back basis).
  • Management added new income‑statement line items for transparency, plans to sell repurchased and affordable assets to return $25–35 million of capital and cut ~$4–5 million of quarterly costs, raised the quarterly dividend to $0.68, and guided 2026 to diluted EPS $3.50–4.00 and adjusted core EPS $4.50–5.00.
  • MarketBeat previews top five stocks to own in April.

Walker & Dunlop NYSE: WD executives said the company’s fourth-quarter and full-year 2025 results reflected strong momentum in its core real estate capital markets franchise, but were weighed down by loan repurchase-related charges and valuation marks tied to strategic decisions made at year-end.

Transaction volumes rose sharply as markets improved

Chairman and CEO Willy Walker said the company saw “significant and sustained growth in transaction volumes” during 2025 as market conditions recovered and Walker & Dunlop’s platform gained traction. Total capital markets transaction volume grew from $7 billion in the first quarter to $18 billion in the fourth quarter, a 161% increase through the year, according to Walker.

In multifamily investment sales, Walker said property sales volumes increased from $1.8 billion in Q1 2025 to $4.5 billion in Q4. He added that the company increased its share of institutional multifamily sales to 10.2% in 2025 from 8.7% in 2024 and finished the year as the fourth-largest multifamily broker, citing Real Estate Alert.

Walker also highlighted cross-platform collaboration, noting that Walker & Dunlop financed 42% of its 2025 multifamily property sales for buyers. He said this contributed to the company finishing 2025 as the largest Fannie Mae DUS lender for the seventh straight year and moving up with Freddie Mac to become the third-largest Optigo lender after growing those volumes 58% in 2025. Overall, Walker said the firm ended the year as the second-largest GSE loan originator with $17.8 billion in total lending volume and 11.2% market share.

Fraud-linked loan review led to Q4 loan loss expense

Management devoted substantial time on the call to loan repurchases and credit matters tied to a Freddie Mac request that the company investigate a portfolio of loans. Walker said Freddie Mac asked the company to investigate a $100 million loan portfolio where a borrower committed fraud by submitting false documents to Walker & Dunlop and Freddie Mac. An outside counsel-led investigation concluded that “not a single employee” had knowledge of or participated in the borrower’s fraudulent transactions, Walker said.

However, Walker added that the investigation also found a banking team had not adhered to loan origination policies and procedures, and that team is no longer with the company. The company then expanded diligence, reviewing approximately 266 loans originated by that team, and identified an additional $34 million loan portfolio where it appeared a borrower misrepresented financial information.

Walker said Walker & Dunlop presented the investigation results to Freddie Mac in January 2026 and offered to indemnify Freddie Mac for losses related to the combined $134 million of loans. CFO Greg Florkowski said the company recorded $29 million of loan loss expense in the fourth quarter related to the investigated loans. Walker said Freddie Mac is performing its own additional review and the company expects Freddie Mac to complete diligence within roughly 90 days.

Year-end strategy shifts triggered impairments and new reporting line items

Florkowski said Walker & Dunlop recognized $66 million of impairments and credit losses in Q4 tied to loan repurchases and a decision to exit certain affordable assets. To improve transparency, the company added two new income statement line items: “Indemnified and repurchased loan expenses” and “Asset impairments and other expenses.”

On loan repurchases, Florkowski said that since 2024 the company has indemnified or repurchased $222 million of loans from the GSEs. In the fourth quarter, it recognized $38 million of charges related to these assets, including the $29 million tied to the investigation. He said the firm is evaluating “the most efficient path to disposition” and expects to execute over the next few quarters, adding that many of the loans remain current and the company does not expect significant carry costs while preparing to sell them.

Florkowski said the remaining $9 million of Q4 charges reflected a strategy change for previously repurchased loans—from long-term hold to near-term exit—after the company spent 2024 stabilizing properties behind those loans. He said those assets cost between $2 million and $3 million per quarter to operate and that holding them for years to recover value would dilute near-term earnings. Going forward, the company plans to report credit reserve adjustments and operating costs for these repurchased assets through the new indemnified and repurchased loan expenses line item.

On affordable assets, Florkowski said the company recorded $26 million of impairment charges tied to assets held since its acquisition of Alliant Capital. He described that portion of the business as focused on raising institutional capital to acquire and operate affordable assets with long hold periods, but noted the business is “not at scale” and operating the assets has cost about $2 million per quarter. Management decided the assets do not align with the company’s long-term strategy and plans to sell them; future gains or losses on sales will run through the new asset impairment line item, he said.

Florkowski said selling repurchased and affordable assets is expected to return $25 million to $35 million of capital to the balance sheet over the coming quarters and eliminate approximately $4 million to $5 million of quarterly operating costs. In Q&A, he added the carry costs will continue in 2026 because the company does not expect an immediate resolution, with costs heavier in the first half and declining through the year.

Reported loss contrasted with “core” earnings power

Because the Q4 charges flowed through GAAP results, Florkowski said the company reported a diluted loss per share of $0.41 for the quarter. He also reported Adjusted EBITDA of $39 million and adjusted core EPS of $0.28, noting that only the credit loss portion of the charges is added back to those non-GAAP measures based on the company’s definitions.

For illustrative purposes, Florkowski said if the remaining impacts of the Q4 charges were added back, diluted EPS would have been $1.04, Adjusted EBITDA would have been $85 million, and adjusted core EPS would have been $1.31. Walker likewise emphasized that excluding impairment and repurchase-related charges, the quarter generated $1.04 in diluted EPS, and he said the company ended 2025 with $299 million of cash.

Segment performance, credit metrics, dividend hike, and 2026 guidance

Florkowski said capital markets delivered $18 billion of transaction volume in Q4, up 36% year-over-year, though revenue did not rise at the same pace. He attributed the gap to volume growth skewing toward debt brokerage and property sales, which carry lower fee margins, while GSE originations remained “tight” and below Q4 of the prior year. The capital markets segment delivered $26 million of net income in Q4 and $90 million for the full year, up 35% from $67 million in 2024.

In servicing and asset management (SAM), Florkowski said the servicing portfolio grew to $144 billion at year-end 2025, up 6% versus the end of 2024. SAM segment revenues were $143 million in Q4, down 9% year-over-year, which he said primarily reflected the absence of a $29 million revenue contribution from an affordable asset sale in Q4 of the prior year. Repurchase and impairment charges of $66 million drove a SAM segment net loss of $9 million compared with $37 million of net income a year earlier, he said.

On credit, Florkowski said the at-risk portfolio with Fannie Mae was $69 billion at Dec. 31, 2025, with 14 defaulted loans totaling $159 million, or 23 basis points of the at-risk portfolio. He cited portfolio statistics including a weighted average debt service coverage ratio over 2x, with 3% of loans below 1x DSCR, and an underwritten loan-to-value ratio of 61%, with 4% of loans underwritten above 75% LTV.

The company also increased its dividend. Florkowski said the board raised the quarterly dividend for the seventh consecutive year to $0.68 per share, a 1.5% increase over 2025, and pointed to the cash balance and cash generation outlook in discussing sustainability.

For 2026, Florkowski guided to diluted earnings per share of $3.50 to $4.00, Adjusted EBITDA of $300 million to $325 million, and adjusted core EPS of $4.50 to $5.00. He said management expects 2026 market growth similar to 2025, continued market share gains, and a stabilizing interest rate environment with only minor reductions to short-term rates.

Walker said the company entered 2026 with a strong pipeline, putting Q1 2026 pipeline at $15 billion—more than 2x Q1 2025 production—and noted an increased combined GSE lending cap of $176 billion for 2026. He also previewed the company’s “Journey to ’30” plan and said Walker & Dunlop will hold an investor day in New York in two weeks to detail the strategy and its goal of growing EPS to $9 by 2030.

About Walker & Dunlop NYSE: WD

Walker & Dunlop is one of the largest providers of commercial real estate finance in the United States, specializing in the origination, servicing and sale of loans secured by multifamily, seniors housing, healthcare, student housing and manufactured housing properties. The firm offers a full suite of debt and equity solutions, including agency financing through Fannie Mae and Freddie Mac, HUD and FHA-insured loans, bridge and construction financing, mezzanine debt, preferred equity, and investment sales advisory.

With roots dating back to 1937 and its headquarters in Bethesda, Maryland, Walker & Dunlop has expanded its platform through both organic growth and strategic acquisitions.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Walker & Dunlop Right Now?

Before you consider Walker & Dunlop, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walker & Dunlop wasn't on the list.

While Walker & Dunlop currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines